Ph.D
Dr. Shao-Wen Hung is a veterinary medicine researcher holding a Doctor of Veterinary Medicine (DVM) and a Ph.D. in Veterinary Medicine from National Chung Hsing University, Taiwan. He is currently serving as a Researcher and Deputy Director in the Division of Sustainable Agriculture, Agricultural Facilities and Environment Research Center, Agricultural Technology Research Institute, Taiwan. His research experience spans oncology, cancer medicine, veterinary immunology, aquatic animal diseases, and experimental disease models. His oncology research has focused on cancer cell signaling, tumor progression and metastasis, apoptosis, and the investigation of potential anticancer therapeutic approaches.
Research on molecular mechanisms involved in cancer progression and metastasis.
Investigation of recombinant viral capsid protein VP1 and its potential anticancer effects.
Research on HER-2 expression, Akt signaling, COX-2/PGE2 pathways, and cancer cell migration and invasion.
Establishment of an anti-lung adenocarcinoma drug-screening platform in mice.
Experimental research involving cell culture, histopathology, Western blotting, PCR, and flow cytometry.
Research and publications in veterinary immunology, disease models, and experimental medicine.
Chen TA, Wang JL, Hung SW, et al. (2011). Recombinant VP1, an Akt inhibitor, suppresses progression of hepatocellular carcinoma by inducing apoptosis and modulation of CCL2 production. PLoS ONE, 6, e23317.
Peng JM, Chen YH, Hung SW, et al. (2012). Recombinant viral protein promotes apoptosis and suppresses invasion of ovarian adenocarcinoma cells by targeting α5β1 integrin to downregulate Akt and MMP-2. British Journal of Pharmacology, 165, 479–493.
Chiu CF, Peng JM, Hung SW, et al. (2012). Recombinant viral capsid protein VP1 suppresses migration and invasion of human cervical cancer by modulating phosphorylated prohibitin in lipid rafts. Cancer Letters, 320, 205–214.
Hung SW, Chiu CF, Chen TA, et al. (2012). Recombinant Viral Protein VP1 Suppresses HER-2 Expression and Migration/Metastasis of Breast Cancer. Breast Cancer Research and Treatment, 136, 89–105.
Ho MY, Hung SW, Liang SM, Liang CM. (2014). Recombinant viral capsid protein VP1 suppresses lung cancer metastasis by inhibiting COX-2/PGE2 and MIG-7. Oncotarget, 5, 3931–3943.
Hung SW, Chen CC, Chiu CC, Lin JW, Yang CY. (2018). Establishment of anti-lung adenocarcinoma drug screening platform in mice. Ilan University Journal of Bioresources, 14, 41–66. (In Chinese.)